£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

2023-2028 US Breast Cancer Screening Outlook by Zip Code

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 17 days · 17 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 07 August 2026 11 August 2026 15 August 2026 19 August 2026
View at Amazon ↗

Price data last checked 74 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 17 days • 1 price levels

Days at Price
17 days 0 4 9 13 17 £490 Days at Price

Price Analysis

Most common price: £490 (17 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 17 days

Description

This specialized report, The 2023-2028 Outlook for Breast Cancer Screenings for US Zip Codes, provides detailed data analysis for the specified period. Published by ICON Group International, Inc., this resource focuses on screening trends across various United States zip codes. It serves as a targeted reference for understanding regional outlooks in the breast cancer screening landscape through 2028. This publication is categorized under Books within the Subjects section, offering a structured look at projected screening data for professional or academic review.

Key Features

Provides a detailed outlook for breast cancer screenings covering the years 2023 through 2028.

Includes specific data organized by US Zip Codes for regional analysis.

Published by ICON Group International, Inc. for professional reference.

Categorized under Books within the Subjects section for easy identification.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
26 January 2023

Similar Products You Might Like

Breast Cancer Diagnostic Products Outlook 2023-2028 Report
99% match

Breast Cancer Diagnostic Products Outlook 2023-2028 Report

£490.00 20 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
99% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
99% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 15 Aug 2026
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
99% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 19 Aug 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
98% match

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

£490.00 31 Oct 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 26 Sep 2026
The 2025-2030 World Outlook for Breast Cancer Screenings
98% match

The 2025-2030 World Outlook for Breast Cancer Screenings

Price unavailable
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 02 Oct 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 15 Aug 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
98% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 26 Sep 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 20 Aug 2026
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
98% match

The 2025-2030 World Outlook for Breast Cancer Diagnostic Products

Price unavailable
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 31 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in India

£515.00 20 Aug 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 15 Aug 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
98% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India
97% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in India

£515.00 22 Aug 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China
97% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in China

£495.00 16 Aug 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
97% match

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

£520.00 19 Aug 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
97% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 02 Oct 2026
The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies
97% match

The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies

£885.00 20 Oct 2026